In contrast to effector T cells, NK cells, DCs, and M1 macrophages, Tregs comprise tumor-promoting immune cells in which the suppressive activity is mediated by key molecules including IL-10, TGF-β, CTLA4, and IL-35. This evidence concerns the gene TGFB1 and neoplasm.